Technology Stocks & Market Talk With Don Wolanchuk Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk

SOXL 44.21

+1.2%

Dec 24 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Winfastorlose who wrote (159408)	8/14/2021 2:09:49 PM
From: TigerPaw	Read Replies (1) of 207444

I've been wondering who is benefiting, and paying for all the anti-vax nonsense. I think one of the answers is the company Genentech. They have been working for years on monoclonal antibody treatments for viral infections and the advent of designer vaccines like mRNA threatens to make their therapy unnecessary. There are some other treatments such as Regeneron and Remdesivir which also have big VC firms backing their investments.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next